GTC Biotherapeutics (fka GTCB)

[keitern]

To summarize my early morning thoughts (LMAO) it seems that a phenomenal company is at risk of being forced to trade large portions of future potential revenue for pennies on the dollar so to speak for lack of capital. Again my thoughts turn to small cash rich, pipeline poor biotechs that may be willing to merge with GTC. If the "perfect storm" has hit small cash flow negative biotechs (SCFNBTs) pronounced "scuf'n'butts" it has equally hit "scurpabutts" (scrppbts) small cash rich, pipeline poor biotechs.
So Dr. Cox and board, start calling some of these companies that are pouring millions into drugs that have little chance for success and hook them up with the future!